These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16773383)

  • 1. [Results of sacral nerve modulation for treatment of overactive bladder].
    Braun PM; Böhler G
    Urologe A; 2006 Jul; 45(7):835-40. PubMed ID: 16773383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neuromodulation in patients with neurogenic overactive bladder.
    Lay AH; Das AK
    Curr Urol Rep; 2012 Oct; 13(5):343-7. PubMed ID: 22865208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacral neuromodulation: No more skiing?
    Wöllner J; Pannek J
    Scand J Urol; 2016; 50(2):132-3. PubMed ID: 26754577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Invasive neurostimulation in neuro-urology: state of the art].
    Kurze I; Böthig R; van Ophoven A
    Aktuelle Urol; 2024 Aug; 55(4):351-364. PubMed ID: 38631373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sacral neuromodulation for neurogenic bladder dysfunction].
    Kessler TM; Wöllner J; Kozomara M; Mordasini L; Mehnert U
    Urologe A; 2012 Feb; 51(2):179-83. PubMed ID: 22269992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
    Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
    World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.
    Tahseen S
    Int Urogynecol J; 2018 Aug; 29(8):1081-1091. PubMed ID: 29302716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
    Chen G; Liao L; Wang Y; Ying X
    Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience.
    Groen LA; Hoebeke P; Loret N; Van Praet C; Van Laecke E; Ann R; Vande Walle J; Everaert K
    J Urol; 2012 Oct; 188(4):1313-7. PubMed ID: 22902022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder.
    Leong RK; de Wachter SG; Joore MA; van Kerrebroeck PE
    BJU Int; 2011 Aug; 108(4):558-64. PubMed ID: 21166750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous tunneling of the temporary testing electrode significantly improves the success rate of subchronic sacral nerve modulation (SNM).
    Sievert KD; Nagele U; Pannek J; Engeler D; Kuczyk M; Stenzl A
    World J Urol; 2007 Dec; 25(6):607-12. PubMed ID: 17912530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre.
    Gajewski JB; Al-Zahrani AA
    BJU Int; 2011 Apr; 107(8):1258-64. PubMed ID: 20883483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacral nerve stimulation: Interstim therapy.
    Peeren F; Hoebeke P; Everaert K
    Expert Rev Med Devices; 2005 May; 2(3):253-8. PubMed ID: 16288588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis.
    Yang G; Xu Y; Qu G; Zhang Y
    PLoS One; 2020; 15(3):e0230355. PubMed ID: 32226049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Duration of Complaints on Successful Outcome of Sacral Neuromodulation.
    Jairam R; Drossaerts J; van Koeveringe G; van Kerrebroeck P
    Urol Int; 2017; 99(1):51-55. PubMed ID: 28478446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SACRAL NEUROMODULATION IN TREATING OVERACTIVE BLADDER PATIENTS - FIRST-TIME APPLICATION IN CROATIA.
    Bakula M; Hauptman D; Hudolin T; Škegro SN; Tudor KI; Bakula B; Kaštelan Ž
    Acta Clin Croat; 2023 Jul; 62(Suppl2):143-147. PubMed ID: 38966014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.